Nutritional composition for treating an immune condition

Details Nutritional composition for treating an immune condition Nutritional composition for treating an immune condition

2005-08-16

2005-08-16

Naff, David M. (Department: 1651)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Bacteria or actinomycetales

C424S439000, C426S061000, C435S170000, C435S252100

Reexamination Certificate

active

06929793

ABSTRACT:
A nutritional composition is described for prevention or treatment of an immune condition. The composition includes at least vitamin E, vitamin C, vitamin B6, folic acid, vitamin B12, copper, zinc, selenium, fructo-oligosaccharides and/or gum acacia, a probiotic lactic acid bacterium. For example, in an embodiment it comprises per 300 g: 150 IU Vitamin E, 120 mg Vitamin C, 2 mg Vitamin B6, 400 ug Folic acid, 3.8 ug Vitamin B12, 1.5 mg Copper, 15 mg Zinc, 100 ug Selenium, 3 g Fructo-oligosaccharides and/or gum acacia, 10E10 cfu ST11 lactobacillus. Also disclosed are a method for making the nutritional composition, a method for manufacturing a functional food or medicament; and a method of prevention or treatment of an immune condition by administering an effective amount of the composition, functional food or medicament.

REFERENCES:
patent: 5147668 (1992-09-01), Munk
patent: 5185321 (1993-02-01), Link et al.
patent: 5882704 (1999-03-01), Yamaguchi et al.
patent: 6241983 (2001-06-01), Paul et al.
patent: 0741995 (1996-11-01), None
patent: 0 904 784 (1999-03-01), None
patent: 0966969 (1999-12-01), None
patent: 2018124 (1979-10-01), None
G. Schaafsma et al., “Effects of Milk Product, Fermented byLactobacillus acidophilusand with Fructo-oligosaccharides Added, on Blood Lipids in Male Volunteers,” European Journal of Clinical Nutrition, vol. 52 no. 6, pp. 436-440, Abstract XP002119336 p. 437. (Jun. 1998).
A. Sullivan et al., “Effect ofLactobacillus paracaseion intestinal colonisation of lactobacilli, bifidobacteria and clostridium difficile in elderly persons,” Abstract XP002194824. (Apr. 2001).
R. Nemcova et al., “Study of the effect ofLactobacillus paracaseiand fructooligosaccharides on the faecal microflora in weanling piglets,” Abstract XP002194825. (Jun.-Jul. 1999).
E. Shiffrin et al., “Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection,” American Journal of Clinical Nutrition, vol. 66, pp. 515s-520s. Abstract XP002194826. (1997).
P. Marteau et al., “Effects of intrajejunal perfusion and chronic ingestion ofLactobacillus johnsoniistrain La1 on serum concentrations and jejunal secretions of immunoglobulins and serum proteins in healthy humans,” Gastroenterol. Clin. Biol., vol. 21, pp. 293-298. Abstract XP001062975. (1997).
J. Spiegel et al., “Safety and Benefits of Fructooligosaccharides as Food Ingredients,” Food Technology, vol. 48, no. 1, pp. 85-89. Abstract XP 000423511. (Jan. 1994).
M. E. Sanders, “Probiotics,” Food Technology, vol. 53, no. 11, pp. 67-75. (Nov. 1999).
C. L. Riedel Abstract of German Patent DD154424; Abstract No. 1982-70334E.

Affiliated with

Also associated with

Rating

Nutritional composition for treating an immune condition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nutritional composition for treating an immune condition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nutritional composition for treating an immune condition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3501355